Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7861417rdf:typepubmed:Citationlld:pubmed
pubmed-article:7861417lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C0000983lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C0029992lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:7861417lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:7861417pubmed:issue4lld:pubmed
pubmed-article:7861417pubmed:dateCreated1995-3-21lld:pubmed
pubmed-article:7861417pubmed:abstractTextAryloxamic acids 7 and 23, (arylamino)acetic acids 29, arylpropionic acids 33, arylthioacetic acids 37, and (aryloxy)acetic acid 41 related to L-triiodothyronine (L-T3) were prepared and tested in vitro for binding to the rat liver nuclear L-T3 receptor and the rat membrane L-T3 receptor. The structure-activity relationships for these compounds are described, with 7f, 23a, 29c, 33a, 37b, and 41 showing excellent potency (IC50's of 0.19, 0.16, 1.1, 0.11, 3.5, and 0.10 nM, respectively) to the nuclear receptor and significantly lower binding affinity to the membrane receptor (IC50's > 5 microM). Some of these compounds, especially in the oxamic acid series 7 and 23, showed an unprecedented potency for methyl-substituted derivatives such as 7f and 23a. Compounds 7f and 23a showed good lipid lowering effects in rats with ED50's of 20 and 5 micrograms/kg po, respectively, and a lack of cardiac side effects in rats at doses as high as 10 and 25 mg/kg po, respectively.lld:pubmed
pubmed-article:7861417pubmed:languageenglld:pubmed
pubmed-article:7861417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:citationSubsetIMlld:pubmed
pubmed-article:7861417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7861417pubmed:statusMEDLINElld:pubmed
pubmed-article:7861417pubmed:monthFeblld:pubmed
pubmed-article:7861417pubmed:issn0022-2623lld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:MainA JAJlld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:YokoyamaNNlld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:BoehmCClld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:WasvaryJ MJMlld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:EngleAAlld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:MorrisseyM...lld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:StantonJ LJLlld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:StephanZ FZFlld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:WalkerG NGNlld:pubmed
pubmed-article:7861417pubmed:authorpubmed-author:NeubertA DADlld:pubmed
pubmed-article:7861417pubmed:issnTypePrintlld:pubmed
pubmed-article:7861417pubmed:day17lld:pubmed
pubmed-article:7861417pubmed:volume38lld:pubmed
pubmed-article:7861417pubmed:ownerNLMlld:pubmed
pubmed-article:7861417pubmed:authorsCompleteNlld:pubmed
pubmed-article:7861417pubmed:pagination695-707lld:pubmed
pubmed-article:7861417pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:meshHeadingpubmed-meshheading:7861417-...lld:pubmed
pubmed-article:7861417pubmed:year1995lld:pubmed
pubmed-article:7861417pubmed:articleTitleSynthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine.lld:pubmed
pubmed-article:7861417pubmed:affiliationResearch Department, Ciba Pharmaceuticals, Summit, New Jersey 07901.lld:pubmed
pubmed-article:7861417pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:7861417lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7861417lld:pubmed